Hanmi Science Co., Ltd.

Hanmi Pharm. Co., Ltd.

Hanmi Holdings Co., Ltd.

Tae Hun Song

Se Chang Kwon

Hwan Mook Kim

Sung Youb Jung

Young Hoon Kim

Hwan Geun Choi

Gwan Sun Lee

In Young Choi

Young Gil Ahn

Tae Bo Sim

Jung Beom Son

Dae Hae Song

Chang Ki Lim

Maeng Sup Kim

Young Jin Ham

Jung Mi Hah

Seung Hyun Jung

Young Hee Jung

Mi Kyoung Lee

Dong-sik Park

Wha Il Choi

Eun Ju Jeon

In Ho Yang

Myoung Sil Ko

The present invention relates to a novel bicyclic heteroaryl derivative, a pharmaceutically acceptable salt thereof, a hydrate thereof, and a solvate thereof having an improved inhibitory activity for protein kinases, and a pharmaceutical composition for preventing or treating an abnormal cell growth disorder comprising same as an active ingredient.

Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase

The present invention relates to an insulinotropic peptide conjugate having improved in-vivo duration of efficacy and stability, comprising an insulinotropic peptide, a non-peptide polymer and an immunoglobulin Fc region, which are covalently linked to each other, and a use of the same. The insulinotropic peptide conjugate of the present invention has the in-vivo activity which is maintained relatively high, and has remarkably increased blood half-life, and thus it can be desirably employed in the development of long acting formulations of various peptide drugs.

Insulinotropic complex using an immunoglobulin fragment

Growing community of inventors

Hwaseong-si, South Korea

Tae Hun Song